GTSF1
gene geneOn this page
Also known as FLJ32942Cue110
Summary
GTSF1 (gametocyte specific factor 1, HGNC:26565) is a protein-coding gene on chromosome 12q13.13, encoding Gametocyte-specific factor 1 (Q8WW33). Required for spermatogenesis and is involved in the suppression of retrotransposon transcription in male germ cells.
Enables tRNA binding activity. Predicted to be involved in piRNA-mediated gene silencing by mRNA destabilization and secondary piRNA processing. Predicted to be located in cytoplasm. Predicted to be active in piP-body.
Source: NCBI Gene 121355 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 4 total
- MANE Select transcript:
NM_144594
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26565 |
| Approved symbol | GTSF1 |
| Name | gametocyte specific factor 1 |
| Location | 12q13.13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ32942, Cue110 |
| Ensembl gene | ENSG00000170627 |
| Ensembl biotype | protein_coding |
| OMIM | 617484 |
| Entrez | 121355 |
Gene structure
Transcript identifiers
Ensembl transcripts: 10 — 4 protein_coding_CDS_not_defined, 3 protein_coding, 2 retained_intron, 1 nonsense_mediated_decay
ENST00000305879, ENST00000546575, ENST00000546739, ENST00000546931, ENST00000548538, ENST00000549083, ENST00000552336, ENST00000552395, ENST00000552397, ENST00000931625
RefSeq mRNA: 1 — MANE Select: NM_144594
NM_144594
CCDS: CCDS8881
Canonical transcript exons
ENST00000305879 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001147644 | 54465067 | 54465167 |
| ENSE00001251872 | 54473546 | 54473602 |
| ENSE00002381273 | 54455957 | 54456153 |
| ENSE00003528206 | 54462642 | 54462725 |
| ENSE00003549436 | 54459089 | 54459125 |
| ENSE00003620439 | 54462109 | 54462172 |
| ENSE00003625785 | 54471233 | 54471277 |
| ENSE00003647524 | 54460377 | 54460471 |
| ENSE00003661301 | 54463171 | 54463297 |
Expression profiles
Bgee: expression breadth ubiquitous, 166 present calls, max score 98.88.
FANTOM5 (CAGE): breadth broad, TPM avg 5.8325 / max 204.1166, expressed in 311 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 131359 | 5.8325 | 311 |
Top tissues by expression
249 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 98.88 | gold quality |
| right testis | UBERON:0004534 | 98.82 | gold quality |
| left testis | UBERON:0004533 | 98.65 | gold quality |
| adult organism | UBERON:0007023 | 97.15 | gold quality |
| testis | UBERON:0000473 | 96.98 | gold quality |
| oocyte | CL:0000023 | 95.80 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 93.86 | gold quality |
| secondary oocyte | CL:0000655 | 91.10 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 90.95 | gold quality |
| ileal mucosa | UBERON:0000331 | 80.07 | silver quality |
| placenta | UBERON:0001987 | 80.05 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 79.47 | gold quality |
| tibialis anterior | UBERON:0001385 | 79.35 | silver quality |
| cardiac muscle of right atrium | UBERON:0003379 | 79.19 | gold quality |
| monocyte | CL:0000576 | 76.50 | gold quality |
| granulocyte | CL:0000094 | 76.45 | gold quality |
| leukocyte | CL:0000738 | 76.45 | gold quality |
| kidney epithelium | UBERON:0004819 | 74.28 | gold quality |
| lymph node | UBERON:0000029 | 74.22 | gold quality |
| vermiform appendix | UBERON:0001154 | 73.08 | gold quality |
| blood | UBERON:0000178 | 71.87 | gold quality |
| spleen | UBERON:0002106 | 71.69 | gold quality |
| bone marrow | UBERON:0002371 | 71.69 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 70.72 | gold quality |
| bone marrow cell | CL:0002092 | 70.31 | gold quality |
| caecum | UBERON:0001153 | 70.09 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 69.30 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 68.91 | gold quality |
| rectum | UBERON:0001052 | 67.96 | gold quality |
| deltoid | UBERON:0001476 | 66.80 | silver quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-134144 | yes | 30.47 |
| E-ANND-3 | no | 3.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
24 targeting GTSF1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3185 | 99.99 | 68.12 | 1959 |
| HSA-MIR-223-3P | 99.99 | 70.14 | 1140 |
| HSA-MIR-6825-5P | 99.96 | 69.81 | 3431 |
| HSA-MIR-10527-5P | 99.91 | 72.28 | 3754 |
| HSA-MIR-4779 | 99.86 | 66.50 | 1583 |
| HSA-MIR-6079 | 99.84 | 68.54 | 1170 |
| HSA-MIR-636 | 99.80 | 69.58 | 1500 |
| HSA-MIR-4760-5P | 99.80 | 69.88 | 1619 |
| HSA-MIR-8061 | 99.63 | 69.44 | 1411 |
| HSA-MIR-12122 | 99.56 | 69.33 | 1672 |
| HSA-MIR-1252-3P | 99.55 | 67.71 | 2862 |
| HSA-MIR-3128 | 99.50 | 67.85 | 1258 |
| HSA-MIR-766-5P | 99.47 | 67.91 | 2225 |
| HSA-MIR-6868-5P | 99.06 | 65.69 | 1284 |
| HSA-MIR-4695-5P | 99.06 | 64.87 | 1151 |
| HSA-MIR-4650-3P | 99.01 | 68.39 | 1062 |
| HSA-MIR-4742-3P | 98.73 | 69.82 | 1803 |
| HSA-MIR-589-5P | 98.72 | 66.96 | 927 |
| HSA-MIR-4266 | 98.53 | 67.29 | 1035 |
| HSA-MIR-4303 | 98.01 | 68.13 | 2304 |
| HSA-MIR-4799-3P | 97.78 | 65.97 | 893 |
| HSA-MIR-4720-5P | 97.46 | 65.67 | 893 |
| HSA-MIR-5588-5P | 97.46 | 65.70 | 913 |
| HSA-MIR-1256 | 95.44 | 66.33 | 784 |
Literature-anchored findings (GeneRIF, showing 2)
- SYCP1, cTAGE1, and GTSF1 are expressed in cutaneous T-cell lymphoma, but not in normal skin or benign inflammatory dermatoses. (PMID:24850846)
- To our knowledge, this report is the first to describe the expression of the human GTSF1 gene in human gametes and preimplantation embryos. (PMID:27646122)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Gtsf1 | ENSMUSG00000022487 |
| rattus_norvegicus | Gtsf1 | ENSRNOG00000036831 |
Paralogs (2): GTSF1L (ENSG00000124196), SNRNP48 (ENSG00000168566)
Protein
Protein identifiers
Gametocyte-specific factor 1 — Q8WW33 (reviewed: Q8WW33)
Alternative names: Protein FAM112B
All UniProt accessions (2): Q8WW33, G3V1V4
UniProt curated annotations — full annotation on UniProt →
Function. Required for spermatogenesis and is involved in the suppression of retrotransposon transcription in male germ cells.
Subcellular location. Cytoplasm.
Similarity. Belongs to the UPF0224 (FAM112) family.
RefSeq proteins (1): NP_653195* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR022776 | TRM13/UPF0224_CHHC_Znf_dom | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR051591 | UPF0224_FAM112_RNA_Proc | Family |
Pfam: PF05253
UniProt features (13 total): binding site 8, zinc finger region 2, chain 1, modified residue 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8WW33-F1 | 76.69 | 0.37 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (8): 71; 17; 23; 33; 37; 51; 57; 67
Post-translational modifications (1): 8
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 80 (showing top):
GOBP_REGULATION_OF_MRNA_CATABOLIC_PROCESS, GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN, GOBP_MACROMOLECULE_CATABOLIC_PROCESS, IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR, GOBP_MALE_GAMETE_GENERATION, GOBP_POST_TRANSCRIPTIONAL_REGULATION_OF_GENE_EXPRESSION, GOBP_REGULATION_OF_CATABOLIC_PROCESS, GOBP_POSITIVE_REGULATION_OF_CATABOLIC_PROCESS, GOBP_PIRNA_PROCESSING, RYTTCCTG_ETS2_B, ELK1_01, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, NRF2_01, GTGACTT_MIR224, IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP
GO Biological Process (4): spermatogenesis (GO:0007283), cell differentiation (GO:0030154), secondary piRNA processing (GO:0140965), piRNA-mediated gene silencing by mRNA destabilization (GO:0140991)
GO Molecular Function (3): tRNA binding (GO:0000049), zinc ion binding (GO:0008270), metal ion binding (GO:0046872)
GO Cellular Component (2): piP-body (GO:0071547), cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| cellular developmental process | 1 |
| piRNA processing | 1 |
| regulatory ncRNA-mediated post-transcriptional gene silencing | 1 |
| mRNA destabilization | 1 |
| RNA binding | 1 |
| transition metal ion binding | 1 |
| cation binding | 1 |
| P granule | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
816 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GTSF1 | PIWIL1 | Q96J94 | 878 |
| GTSF1 | PIWIL4 | Q7Z3Z4 | 836 |
| GTSF1 | PIWIL2 | Q8TC59 | 698 |
| GTSF1 | MOV10L1 | Q9BXT6 | 667 |
| GTSF1 | TDRD9 | Q8NDG6 | 662 |
| GTSF1 | TDRD1 | Q9BXT4 | 626 |
| GTSF1 | ERI1 | Q8IV48 | 615 |
| GTSF1 | HENMT1 | Q5T8I9 | 602 |
| GTSF1 | TDRD12 | Q587J7 | 600 |
| GTSF1 | TDRKH | Q9Y2W6 | 591 |
| GTSF1 | MAEL | Q96JY0 | 584 |
| GTSF1 | EXD1 | Q8NHP7 | 546 |
| GTSF1 | FKBP6 | O75344 | 545 |
| GTSF1 | NXF2B | Q9GZY0 | 529 |
| GTSF1 | SNRNP48 | Q6IEG0 | 515 |
IntAct
15 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GTSF1 | LRRK2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GTSF1 | MFHAS1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GTSF1 | UBR3 | psi-mi:“MI:0915”(physical association) | 0.400 |
| HSPB1 | GTSF1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| GTSF1 | HSPB1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| GTSF1 | MAPK14 | psi-mi:“MI:0914”(association) | 0.350 |
| PAAT | HIP1 | psi-mi:“MI:0914”(association) | 0.350 |
| DGCR8 | VWA8 | psi-mi:“MI:2364”(proximity) | 0.270 |
| LIN28B | MEX3A | psi-mi:“MI:2364”(proximity) | 0.270 |
| QKI | SMCHD1 | psi-mi:“MI:2364”(proximity) | 0.270 |
| RPS3 | ESYT2 | psi-mi:“MI:2364”(proximity) | 0.270 |
| ZC3H11A | ESYT2 | psi-mi:“MI:2364”(proximity) | 0.270 |
| DDX6 | RPSA2 | psi-mi:“MI:2364”(proximity) | 0.270 |
BioGRID (13): GTSF1 (Two-hybrid), RGP1 (Affinity Capture-MS), MAPK14 (Affinity Capture-MS), GTSF1 (Reconstituted Complex), GTSF1 (Reconstituted Complex), GTSF1 (Proximity Label-MS), GTSF1 (Proximity Label-MS), GTSF1 (Proximity Label-MS), MAPK14 (Affinity Capture-MS), RGP1 (Affinity Capture-MS), UBR3 (Affinity Capture-MS), GTSF1 (Affinity Capture-MS), GTSF1 (Protein-peptide)
ESM2 similar proteins: A0JMR6, A4IIA7, A5WW08, O60934, P14629, P55265, P79457, Q13434, Q149N8, Q2YDS5, Q3B7T1, Q3KQ71, Q3SZU0, Q3T026, Q3UDK1, Q4R8M9, Q4VBT5, Q561R3, Q5FWP4, Q5R4U2, Q5RCV3, Q5RGA4, Q5RL73, Q5VVJ2, Q66J91, Q69Z66, Q6A098, Q6IEG0, Q6P256, Q6PFK1, Q7TN31, Q7ZZ00, Q8JFF3, Q8K2X2, Q8N302, Q8S4P6, Q8WW33, Q93073, Q96T68, Q99MM4
Diamond homologs: P13007, Q3SZU0, Q4R8M9, Q8WW33, Q9DAN6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
4 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 3 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
973 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 12:54459087:A:AC | donor_gain | 1.0000 |
| 12:54459088:C:CC | donor_gain | 1.0000 |
| 12:54460375:A:AC | donor_gain | 1.0000 |
| 12:54460376:C:CC | donor_gain | 1.0000 |
| 12:54460376:CT:C | donor_gain | 1.0000 |
| 12:54460472:C:CC | acceptor_gain | 1.0000 |
| 12:54462636:GCTCA:G | donor_loss | 1.0000 |
| 12:54462637:CTCAC:C | donor_loss | 1.0000 |
| 12:54462638:TCA:T | donor_loss | 1.0000 |
| 12:54462639:CA:C | donor_loss | 1.0000 |
| 12:54462640:A:AT | donor_loss | 1.0000 |
| 12:54462641:C:CA | donor_loss | 1.0000 |
| 12:54462721:GTTGA:G | acceptor_gain | 1.0000 |
| 12:54462722:TTGA:T | acceptor_gain | 1.0000 |
| 12:54462723:TGA:T | acceptor_gain | 1.0000 |
| 12:54462724:GA:G | acceptor_gain | 1.0000 |
| 12:54462725:AC:A | acceptor_loss | 1.0000 |
| 12:54462726:C:CA | acceptor_loss | 1.0000 |
| 12:54462726:C:CC | acceptor_gain | 1.0000 |
| 12:54462727:T:G | acceptor_loss | 1.0000 |
| 12:54463166:CTTA:C | donor_loss | 1.0000 |
| 12:54463167:TTAC:T | donor_loss | 1.0000 |
| 12:54463168:TACC:T | donor_loss | 1.0000 |
| 12:54463169:A:AC | donor_gain | 1.0000 |
| 12:54463169:ACC:A | donor_loss | 1.0000 |
| 12:54463170:C:CC | donor_gain | 1.0000 |
| 12:54463170:C:CT | donor_loss | 1.0000 |
| 12:54463170:CCAA:C | donor_gain | 1.0000 |
| 12:54463174:CAT:C | donor_gain | 1.0000 |
| 12:54463193:T:TA | donor_gain | 1.0000 |
AlphaMissense
1122 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 12:54463264:A:G | C51R | 1.000 |
| 12:54465074:C:G | C37S | 1.000 |
| 12:54465075:A:G | C37R | 1.000 |
| 12:54465075:A:T | C37S | 1.000 |
| 12:54465083:A:G | L34P | 1.000 |
| 12:54465085:A:C | H33Q | 1.000 |
| 12:54465085:A:T | H33Q | 1.000 |
| 12:54465087:G:C | H33D | 1.000 |
| 12:54465087:G:T | H33N | 1.000 |
| 12:54465098:C:A | R29M | 1.000 |
| 12:54465115:A:C | H23Q | 1.000 |
| 12:54465115:A:T | H23Q | 1.000 |
| 12:54465117:G:C | H23D | 1.000 |
| 12:54465134:C:G | C17S | 1.000 |
| 12:54465135:A:G | C17R | 1.000 |
| 12:54465135:A:T | C17S | 1.000 |
| 12:54462649:C:A | W107C | 0.999 |
| 12:54462649:C:G | W107C | 0.999 |
| 12:54462651:A:G | W107R | 0.999 |
| 12:54462651:A:T | W107R | 0.999 |
| 12:54463203:C:G | C71S | 0.999 |
| 12:54463203:C:T | C71Y | 0.999 |
| 12:54463204:A:G | C71R | 0.999 |
| 12:54463204:A:T | C71S | 0.999 |
| 12:54463214:A:C | H67Q | 0.999 |
| 12:54463214:A:T | H67Q | 0.999 |
| 12:54463244:G:C | H57Q | 0.999 |
| 12:54463244:G:T | H57Q | 0.999 |
| 12:54463251:G:T | A55D | 0.999 |
| 12:54463253:A:C | N54K | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000090565 (12:54473639 A>G), RS1000283501 (12:54459880 C>T), RS1000325094 (12:54464399 G>T), RS1000382262 (12:54468060 C>T), RS1000397881 (12:54460021 C>T), RS1000798618 (12:54469723 C>A,G), RS1000930467 (12:54462674 T>C), RS1001091115 (12:54472233 G>A,C), RS1001200658 (12:54456486 C>G), RS1001251951 (12:54471027 T>C,G), RS1001316676 (12:54456300 A>G), RS1001362379 (12:54456259 G>T), RS1001870758 (12:54475319 G>A), RS1001944825 (12:54469179 A>G), RS1002068067 (12:54461619 G>T)
Disease associations
OMIM: gene MIM:617484 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, increases expression, affects expression, increases methylation | 8 |
| beta-methylcholine | affects expression | 1 |
| entinostat | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | increases expression, affects cotreatment | 1 |
| dorsomorphin | affects cotreatment, increases expression | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Antirheumatic Agents | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.